85
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Helicobacter pylori , Non-steroidal Anti-inflammatory Drugs and Smoking in Risk Pattern of Gastroduodenal Ulcers

, , , , , , , & show all
Pages 923-930 | Published online: 08 Jul 2009

  • Kontiirek SJ. Stomach and duodenum. In: Konturek SJ editor. Clinical gastroenterology and hepatology, PZWL Warszawa: 2001. p. 124-206.
  • Westhrook JI, Rushworth RL. The epidemiology of peptic ulcer mortality 1953-1989: a birth cohort analysis. Int J Epidemiol 1993:22:1085-92.
  • Bielanski W. Lpidemiological study on Helicobacler pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 1999:50:723-34.
  • Rauws EA, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990:335:1233-5.
  • Lai KC, Hui WM, Wong WM', Wong BC, Hu WH, Ching CK, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage: a long-term randomized, controlled study. Am J Gastroenterol 2000:95:2225-32.
  • Sonnenberg A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther 1995:9 Suppl 2:3-12.
  • Xia HH-X, Talley NJ. Prospects for improved therapy for Helicobacter pylori infection. Exp Opin Invest Drugs 1996:5: 959-76.
  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984:1:1311-5.
  • Henry A, Batey RG. Low prevalence of Helicobacter pylori in an Australian duodenal population: NSAID it is or the effect of ten years of H. pylori treatment? Aust NZ J Med 1998:28:345.
  • Xia HH-X, Kalantar JS, Mitchell HM, Talley NJ. Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 200 14615-24.
  • Xia HH, Wong BC, Wong KW, Wong SY, Wong WM, Lai KC, et al. Clinical and endoscopie characteristics of non-Helicohacter priori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001:15:1875-82.
  • Borody TJ, George LL, Brandi S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991:86:1154-7.
  • Nensey YM, Schubert TT, Bologna SD, Ma KC. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991:91:15-8.
  • Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopie characteristics of Helicobacler pylori positive and negative peptic ulcer disease. Med J Aust 2000:173:508-9.
  • McCoIl KEL. Helicobacfer pylori negative ulcer disease. Dig Liver Dis 2000:32:125-7.
  • Pawlik T, Konturek PC, Konturek JW, Konturek SJ, Brzozowski T, Czesnikiewicz M, et al. Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experiments on animals and humans. Lur J Pharmacol 2002:449: 1-2.
  • Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced ulcer management (OMNIUM) study group. N Engl J Med 1998:38: 727-34.
  • Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid suppression trial: ranitidine versus omeprazole for NSAID-associated ulcer treatment (ASTRONAUT) Study Group. N Engl J Med 1998:38:719-26.
  • Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, et al. Does eradication of Helicohacter pylori impair healing of nonsteroidal anti-inflammatory drugs associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998:12:1201-5.
  • Chan FK, Sung JJ, Chung SC, Chung SC, To KF, Yung MY, et al. Randomized trial of eradication of Helicohacter priori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997:350:975-9.
  • Caselli M, Pazzi P, LaCorte R, Aleotti A, Trevisani L, Stabellini G. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatic arthritis. Digestion 1989:44:101-4.
  • Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal antiinflammatory drug induced gastrointestinal damage in rheumatoid arthritis. Gut 1993:34:1677-80.
  • Eastwood GI. Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol 1997:25 Suppl 1 :Sl-7.
  • Ma L, Chow JY, Clio CH. Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanism of action. J Clin Gastroenterol 1998:27 Suppl l:S80-6.
  • Bielanski W, Konturek SJ. New approach to C-urea breath test: capsule-based modification with low-dose of C-urea in the diagnostic of Helicobacter pylori infection. J Physiol Pharmacol 1996:47:545-53.
  • Borody TJ, George LL, Brandi S, Andrews P, Kjankiewicz E, Ostapowicz N. Smoking does not contribute to duodenal ulcer release after Helicobacter pylori eradication. Am J Gastroenterol 1992:87:1390-3.
  • Chan FK, Sung JJ, Lee YT, Leung WK, Chan LY, Yung MY, et al. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Am J Gastroenterol 1997:92: 442-5.
  • Hui WM, Shin LP, Lok AS, Lam SK. A prospective study of patients with active disease and in remission. Digestion 1992:52: 165-72.
  • Levenstein S, Ackerman S, Kiecolt-Glaser JK, Dubois A. Stress and peptic ulcer disease. J Am Med Assoc 1999:281:10-11.
  • Misciagna G, Cisternino AM, Freudenlieim J. Diet and duodenal ulcer. Dig Liver Dis 2000:32:468-72.
  • Hyvarinen H, Salmenkyla S, Sipponen P. Helicohacfer pylorinegative duodenal and pyloric ulcer: role of NSAIDs. Digestion 1996:57:305-9.
  • Chan FK, Sung JJ. How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs? Bailieres Clin Gastroenterol 2000:14:161-72.
  • Graham DY. Role of Helicohucter pylori in NSAID gastropathy: can H. pylori infection be beneficial? In: Hunt RH, Tytgat GNJ, editors. Helicohucter pylori: basic mechanisms to clinical cure 2000. London: Kluwer Academic Publishers; 2000. p. 453-60.
  • Hawkey CJ. Helicobacter pylori and non-steroidal anti-inflammatory drugs. In: Hunt RH, Tytgat GNI, editors. Helicobacter pylori: basic mechanisms to clinical cure 2000. London: Kluwer Academic Publishers: 2000. p. 461-6.
  • Hawkey CI. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000:1 19:521-35.
  • Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992; 102:1899-905.
  • Vcev A, Ivandic A, Vceva A, Stimac D, Tahac B, Mikolasevic S, et al. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs. Acta Med Croatica 1998; 52:27-31.
  • Bianchi Porro G, Parente F, Imhesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long term NSAID users: response to omeprazole dual therapy. Gut 1996:39:22-6.
  • Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomized controlled trial of Helicobacter priori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998:352:1016-21.
  • Huang J-Q, Sridhar S, Hunt RH. Role of Helicohacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet 2002:359:14-22.
  • Laine L, Marin-Sorensen M, Weinstein WM. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992:87:1398-402.
  • Lanas A, Sekar C, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992:103:862-89.
  • Lanas A, Serrano P, Bajador E, Esteve F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997:112:683-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.